EUVIMEDEUVIMED entdecken
Crossref

Identification of novel anti‐leishmanials targeting glutathione synthetase of the parasite: a drug repurposing approach

Manash Sarma, Kushal Bora, Preeti Ranjan, Vikash Kumar Dubey iD

FEBS Letters · 2025

DOI: 10.1002/1873-3468.15016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FEBS Letters, 2025. Verfasst von Manash Sarma und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biochemical Engineering, Indian Institute of Technology (BHU), Varanasi, India. Hauptthemen laut MEDLINE: Drug Repositioning, Leishmania donovani, Glutathione Synthase, Antiprotozoal Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug repurposing has emerged as an effective strategy against infectious diseases such as visceral leishmaniasis. Here, we evaluated four FDA‐approved drugs–valrubicin, ciclesonide, deflazacort, and telithromycin—for their anti‐leishmanial activity on Leishmania donovani parasites, especially their ability to target the enzyme glutathione synthetase ( Ld GS), which enables parasite survival under oxidative stress in host macrophages. Valrubicin and ciclesonide exhibited superior inhibitory effects compared to deflazacort and telithromycin, inhibiting the promastigotes at very low concentrations, with IC 50 values of 1.09 ± 0.09 μ m and 2.09 ± 0.09 μ m , respectively. Subsequent testing on amastigotes revealed the IC 50 values of 1.74 ± 0.05 μ m and 3.32 ± 0.21 μ m for valrubicin and ciclesonide, respectively. Molecular and cellular level analysis further elucidated the mechanisms underlying the anti‐leishmanial activity of valrubicin and ciclesonide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningLeishmania donovaniGlutathione SynthaseAntiprotozoal AgentsAnimalsHumansMacrophagesMiceLeishmaniasis, Visceral

Stichwörter der Autor:innen

Kala‐azarLeishmaniabiochemistrydrug discoveryenzyme

Substanzen

Glutathione SynthaseAntiprotozoal Agents

Autor:innen und Institutionen

  • School of Biochemical Engineering, Indian Institute of Technology (BHU), Varanasi, India.

ORCID-Profile: Vikash Kumar Dubey

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Sarma, M., Bora, K., Ranjan, P., & Dubey, V. K. (2025). Identification of novel anti‐leishmanials targeting glutathione synthetase of the parasite: a drug repurposing approach. FEBS Letters. https://doi.org/10.1002/1873-3468.15016

Vancouver

Sarma M, Bora K, Ranjan P, Dubey VK. Identification of novel anti‐leishmanials targeting glutathione synthetase of the parasite: a drug repurposing approach. FEBS Letters. 2025. doi:10.1002/1873-3468.15016

BibTeX
@article{Sarma2025,
  author = {Sarma, Manash and Bora, Kushal and Ranjan, Preeti and Dubey, Vikash Kumar},
  title = {Identification of novel anti‐leishmanials targeting glutathione synthetase of the parasite: a drug repurposing approach},
  journal = {FEBS Letters},
  year = {2025},
  doi = {10.1002/1873-3468.15016}
}
Kostenlos starten →